Soleno Therapeutics Files 8-K on Operations and Financials
Ticker: SLNO · Form: 8-K · Filed: May 7, 2025 · CIK: 1484565
| Field | Detail |
|---|---|
| Company | Soleno Therapeutics Inc (SLNO) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, sec-filing
TL;DR
SOLENO filed an 8-K on May 7th covering financials and operations.
AI Summary
On May 7, 2025, Soleno Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This filing indicates Soleno Therapeutics is providing updates on its financial health and operational performance to the SEC, which is important for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting operational and financial information, with no immediate indication of significant risk events.
Key Players & Entities
- SOLENO THERAPEUTICS, INC. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 001-36593 (company_id) — Commission File Number
- 77-0523891 (company_id) — IRS Employer Identification Number
- 100 Marine Parkway, Suite 400 Redwood City, CA 94065 (address) — Principal executive offices
- 650-213-8444 (phone_number) — Registrant's telephone number
- May 7, 2025 (date) — Date of earliest event reported
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided excerpt of the 8-K filing indicates it concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not detail specific financial figures or operational updates.
When was this 8-K report filed by Soleno Therapeutics, Inc.?
The 8-K report was filed on May 7, 2025.
What is Soleno Therapeutics, Inc.'s principal executive office address?
Soleno Therapeutics, Inc.'s principal executive offices are located at 100 Marine Parkway, Suite 400, Redwood City, CA 94065.
What is the Commission File Number for Soleno Therapeutics, Inc.?
The Commission File Number for Soleno Therapeutics, Inc. is 001-36593.
What is the IRS Employer Identification Number for Soleno Therapeutics, Inc.?
The IRS Employer Identification Number for Soleno Therapeutics, Inc. is 77-0523891.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding SOLENO THERAPEUTICS INC (SLNO).